(a).
Patient group | Method | Negative | Weekly positive | Positive | Strongly positive |
---|---|---|---|---|---|
a-pANCA IgG | IIF | 1 | 3 | 14 | 7 |
a-pANCA IgA | IIF | 20 | 0 | 3 | 2 |
ANCA profile IgG | ELISA | 21 | 2 (2x PR3) | 2 (2x ELA) | 0 |
ANA IgG | IIF | 24 | 0 | 1 (granular) | 0 |
ASCA IgA | IIF | 25 | 0 | 0 | 0 |
a-ENDO IgA | IIF | 10 | 0 | 0 | 0 |
a-ENDO IgG | IIF | 10 | 0 | 0 | 0 |
a-tTg IgA | ELISA | 13 | 0 | 0 | 0 |
a-tTg IgG | ELISA | 13 | 0 | 0 | 0 |